Company: PGEN
Filing Date: 2025-05-06
Form Type: PRE 14A
Source: 0001140361-25-017535
Chunk: 69

Company: PRECIGEN, INC.
Filing Date: 2025-05-06
Form: PRE 14A
Chunk 69
---
 of grant, with the balance of the awards vesting in 36 successive equal monthly installments thereafter, except as noted in (2) below. |

| (2) | Award vested on the first anniversary of the grant date. |

| (3) | Award vests in two equal 50% installments based upon the achievement of two specified operational milestones relating to (i) the Company’s good faith submission to the FDA of a complete BLA for the Company’s PRGN-2012 investigational product and (ii) the approval of the BLA by the FDA. |

| (4) | In connection with his separation from employment in November 2024, all of Mr. Perez’s outstanding, unvested equity awards were forfeited. Under the terms of his employment agreement, he has five months from the date of his termination to exercise his outstanding, vested options. |

51

TABLE OF CONTENTS

STOCK AWARDS VESTED FOR 2024 The following table sets forth specified information concerning stock vesting for each of the named executive officers during the fiscal year ended December 31, 2024.

| Name                |                     |     | Stock Awards |                |     |           |
|                     | Number of Shares    
 Acquired on Vesting 
 (#)                 |     |              | Value Realized 
 on Vesting     
 ($)(1)         |     |           |
| Helen Sabzevari     |                     |     |    1,071,428 |                |     | 1,499,999 |
| Harry Thomasian Jr. |                     |     |      135,714 |                |     |   190,000 |
| Donald P. Lehr      |                     |     |      164,285 |                |     |   229,999 |
| Rutul R. Shah       |                     |     |      117,142 |                |     |   163,999 |
| Phil Tennant        |                     |     |            — |                |     |         — |
| Jeffrey Perez       |                     |     |      142,857 |                |     |   200,000 |

| (1) | The amounts in the “Value Realized on Vesting” column are calculated based on the closing market price per share of our common stock on the date of vesting. This calculation differs from the grant date fair value of the equity awards determined in accordance with ASC Topic 718. |

52

TABLE OF CONTENTS POTENTIAL